Phytantriol Based "Stealth" Lyotropic Liquid Crystalline Nanoparticles for Improved Antitumor Efficacy and Reduced Toxicity of Docetaxel.
作者： Sanyog Jain , Neha Bhankur , Nitin K. Swarnakar , Kaushik Thanki
DOI: 10.1007/S11095-015-1706-2
关键词: Reduced toxicity 、 Pharmacology toxicology 、 Nanotechnology 、 PEGylation 、 Lyotropic 、 Chemistry 、 Docetaxel 、 Surface modification 、 Liquid crystalline 、 Pharmacology 、 Nanoparticle
摘要: Purpose The present work focuses on design and development of surface functionalized LCNPs for improving tumor delivery DTX.
springer.com
sci-hub.se 参考文章(35)
Shakila B Rizwan, Ben J Boyd, Thomas Rades, Sarah Hook, Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins. Expert Opinion on Drug Delivery. ,vol. 7, pp. 1133- 1144 ,(2010) , 10.1517/17425247.2010.515584
Marie-Christine Bissery, Gerhard Nohynek, Ger-Jan Sanderink, François Lavelie, Docetaxel (Taxotere®) a review of preclinical and clinical experience. Part I: preclinical experience Anti-Cancer Drugs. ,vol. 6, pp. 339- 355 ,(1995) , 10.1097/00001813-199506000-00001
Atul Kolate, Dipesh Baradia, Sushilkumar Patil, Imran Vhora, Girish Kore, Ambikanandan Misra, PEG — A versatile conjugating ligand for drugs and drug delivery systems Journal of Controlled Release. ,vol. 192, pp. 67- 81 ,(2014) , 10.1016/J.JCONREL.2014.06.046
Justas Barauskas, Camilla Cervin, Marija Jankunec, Marija Špandyreva, Kristina Ribokaitė, Fredrik Tiberg, Markus Johnsson, Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes. International Journal of Pharmaceutics. ,vol. 391, pp. 284- 291 ,(2010) , 10.1016/J.IJPHARM.2010.03.016
H Maeda, J Wu, T Sawa, Y Matsumura, K Hori, Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. Journal of Controlled Release. ,vol. 65, pp. 271- 284 ,(2000) , 10.1016/S0168-3659(99)00248-5
Kaushik Thanki, Rahul P. Gangwal, Abhay T. Sangamwar, Sanyog Jain, Oral delivery of anticancer drugs: Challenges and opportunities Journal of Controlled Release. ,vol. 170, pp. 15- 40 ,(2013) , 10.1016/J.JCONREL.2013.04.020
F K Engels, A Sparreboom, R A A Mathot, J Verweij, Potential for improvement of docetaxel-based chemotherapy: a pharmacological review British Journal of Cancer. ,vol. 93, pp. 173- 177 ,(2005) , 10.1038/SJ.BJC.6602698
Andreas Wicki, Dominik Witzigmann, Vimalkumar Balasubramanian, Jörg Huwyler, Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. Journal of Controlled Release. ,vol. 200, pp. 138- 157 ,(2015) , 10.1016/J.JCONREL.2014.12.030
Vinodh R. Nannan Panday, Manon T. Huizing, Wim W. Ten Bokkel Huinink, Jan B. Vermorken, Jos H. Beijnen, Hypersensitivity reactions to the taxanes paclitaxel and docetaxel Clinical Drug Investigation. ,vol. 14, pp. 418- 427 ,(1997) , 10.2165/00044011-199714050-00011
S BAKER, J LI, A TENTIJE, W FIGG, W GRAVELAND, J VERWEIJ, A SPARREBOOM, Relationship of systemic exposure to unbound docetaxel and neutropenia. Clinical Pharmacology & Therapeutics. ,vol. 77, pp. 43- 53 ,(2005) , 10.1016/J.CLPT.2004.09.005